- Home
- LGCB vs APM Comparison
LGCB vs APM Comparison
Compare LGCB & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LGCB | APM |
|---|---|---|
| Founded | 2011 | 2010 |
| Country | Japan | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.4M | 18.9M |
| IPO Year | 2023 | 2018 |
Fundamental Metrics
Financial Performance| Metric | LGCB | APM |
|---|---|---|
| Price | $2.06 | $1.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 76.6K | ★ 107.4K |
| Earning Date | 07-03-2025 | 12-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,993,265.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.80 | N/A |
| 52 Week Low | $1.22 | $0.65 |
| 52 Week High | $6.83 | $7.49 |
Technical Indicators
Market Signals| Indicator | LGCB | APM |
|---|---|---|
| Relative Strength Index (RSI) | 55.85 | 43.44 |
| Support Level | $1.85 | $1.27 |
| Resistance Level | $2.12 | $1.38 |
| Average True Range (ATR) | 0.13 | 0.14 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 65.55 | 21.57 |
Price Performance
Historical ComparisonAbout LGCB Linkage Global Inc
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.